应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TXG 10x Genomics, Inc.
未开盘 11-04 16:00:00 EST
67.52
+2.23
+3.42%
盘后
66.50
-1.02
-1.51%
19:52 EST
最高
68.32
最低
62.88
成交量
292.38万
今开
68.25
昨收
65.29
日振幅
8.33%
总市值
87.97亿
流通市值
79.67亿
总股本
1.30亿
成交额
1.93亿
换手率
2.48%
流通股本
1.18亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|10x Genomics, Inc.夜盘下跌6.02%,AI单细胞分析工具发布后市场仍偏审慎
行情直击 · 11-04 09:44
异动解读|10x Genomics, Inc.夜盘下跌6.02%,AI单细胞分析工具发布后市场仍偏审慎
异动解读|10x Genomics, Inc.盘中上涨5.42%,AI单细胞分析工具发布带动关注
行情直击 · 11-03 22:40
异动解读|10x Genomics, Inc.盘中上涨5.42%,AI单细胞分析工具发布带动关注
异动解读|10x Genomics, Inc.盘中下跌5.04%,AI单细胞分析工具发布未扭转谨慎情绪
行情直击 · 11-02 23:37
异动解读|10x Genomics, Inc.盘中下跌5.04%,AI单细胞分析工具发布未扭转谨慎情绪
异动解读|10x Genomics, Inc.盘中下跌9.15%,财报前机构观点偏审慎
行情直击 · 10-30
异动解读|10x Genomics, Inc.盘中下跌9.15%,财报前机构观点偏审慎
异动解读|10x Genomics, Inc.盘前下跌5.58%,财报前机构观点偏审慎
行情直击 · 10-30
异动解读|10x Genomics, Inc.盘前下跌5.58%,财报前机构观点偏审慎
财报前瞻 | 10x Genomics, Inc.本季度营收预计小幅增长,机构观点偏审慎
财报Agent · 10-29
财报前瞻 | 10x Genomics, Inc.本季度营收预计小幅增长,机构观点偏审慎
异动解读|10x Genomics, Inc.盘中上涨5.42%,机构上调目标价后股价维持强势
行情直击 · 10-28
异动解读|10x Genomics, Inc.盘中上涨5.42%,机构上调目标价后股价维持强势
异动解读|10x Genomics, Inc.盘中上涨5.16%,机构上调目标价后股价维持强势
行情直击 · 10-27
异动解读|10x Genomics, Inc.盘中上涨5.16%,机构上调目标价后股价维持强势
异动解读|10x Genomics盘中下跌5.22%,报72.14美元
行情直击 · 10-22
异动解读|10x Genomics盘中下跌5.22%,报72.14美元
异动解读|10x Genomics盘中上涨5.4%,暂无明确新催化剂
行情直击 · 10-21
异动解读|10x Genomics盘中上涨5.4%,暂无明确新催化剂
异动解读|10x Genomics盘中下跌5.24%,股价延续回调且缺乏新增明确催化
行情直击 · 10-16
异动解读|10x Genomics盘中下跌5.24%,股价延续回调且缺乏新增明确催化
异动解读|10x Genomics盘中下跌5.02%,股价延续回调且缺乏新增明确催化
行情直击 · 10-15
异动解读|10x Genomics盘中下跌5.02%,股价延续回调且缺乏新增明确催化
异动解读|10x Genomics盘中下跌5.17%,行业整体走弱叠加市场情绪谨慎
行情直击 · 10-12
异动解读|10x Genomics盘中下跌5.17%,行业整体走弱叠加市场情绪谨慎
异动解读|10x Genomics盘中上涨6.25%,美银上调目标价提振市场情绪
行情直击 · 10-09
异动解读|10x Genomics盘中上涨6.25%,美银上调目标价提振市场情绪
异动解读|10x Genomics盘中下跌5.26%,Fred Hutchinson合作未能提振市场信心
行情直击 · 10-08
异动解读|10x Genomics盘中下跌5.26%,Fred Hutchinson合作未能提振市场信心
异动解读|10x Genomics盘前下跌5.15%,与Fred Hutchinson合作未能提振市场信心
行情直击 · 10-08
异动解读|10x Genomics盘前下跌5.15%,与Fred Hutchinson合作未能提振市场信心
异动解读|10x Genomics盘中下跌6.72%,生命科学工具板块集体走弱
行情直击 · 10-07
异动解读|10x Genomics盘中下跌6.72%,生命科学工具板块集体走弱
异动解读|10x Genomics盘中下跌6.13%,行业板块集体回调施压
行情直击 · 10-06
异动解读|10x Genomics盘中下跌6.13%,行业板块集体回调施压
异动解读|10x Genomics盘中上涨5.06%,首批Atera平台商业发货落地叠加投行看好
行情直击 · 10-06
异动解读|10x Genomics盘中上涨5.06%,首批Atera平台商业发货落地叠加投行看好
异动解读|10x Genomics盘中上涨5.55%,新平台Atera启动商业发货叠加投行看多
行情直击 · 10-02
异动解读|10x Genomics盘中上涨5.55%,新平台Atera启动商业发货叠加投行看多
加载更多
公司概况
公司名称:
10x Genomics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
10x Genomics, Inc.于2012年7月2日在特拉华州注册成立。该公司是一家生命科学技术公司,专注于开发创新的产品和解决方案,以探究、理解并掌控生物学。该公司的集成研究解决方案包括用于分析生物系统的仪器、耗材和软件,其分析的分辨率和规模能够与生物学的复杂性相匹配。
发行价格:
--
{"stockData":{"symbol":"TXG","market":"US","secType":"STK","nameCN":"10x Genomics, Inc.","latestPrice":67.52,"timestamp":1793826000000,"preClose":65.29,"halted":0,"volume":2923798,"hourTrading":{"tag":"盘后","latestPrice":66.5014,"preClose":67.52,"latestTime":"19:52 EST","volume":138609,"amount":9348234.4382,"timestamp":1793839974532,"change":-1.0186,"changeRate":-0.015086,"amplitude":0.023944},"delay":0,"changeRate":0.03415530709143804,"floatShares":118000000,"shares":130291168,"eps":-0.58837,"marketStatus":"未开盘","change":2.23,"latestTime":"11-04 16:00:00 EST","open":68.245,"high":68.3167,"low":62.88,"amount":193384747.96795198,"amplitude":0.08327,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.58837,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793869200000},"marketStatusCode":0,"adr":0,"listingDate":1568260800000,"exchange":"NASDAQ","adjPreClose":65.29,"preHourTrading":{"tag":"盘前","latestPrice":67.01,"preClose":65.29,"latestTime":"09:29 EST","volume":6454,"amount":430419.38982000004,"timestamp":1793802599999,"change":1.72,"changeRate":0.026344,"amplitude":0.091438},"postHourTrading":{"tag":"盘后","latestPrice":66.5014,"preClose":67.52,"latestTime":"19:52 EST","volume":138609,"amount":9348234.4382,"timestamp":1793839974532,"change":-1.0186,"changeRate":-0.015086,"amplitude":0.023944},"volumeRatio":0.733457,"impliedVol":1.09,"impliedVolPercentile":0.9721},"requestUrl":"/m/hq/s/TXG","defaultTab":"news","newsList":[{"id":"1180692179","title":"异动解读|10x Genomics, Inc.夜盘下跌6.02%,AI单细胞分析工具发布后市场仍偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1180692179","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180692179?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:44","pubTimestamp":1793756680,"startTime":"0","endTime":"0","summary":"11月4日,10x Genomics, Inc.夜盘下跌6.02%,报61.36美元/股,成交额5.15万美元。消息面上,公司近期发布云端AI应用Sentira Single Cell,支持研究人员以自然语言分析Chromium单细胞数据,但新品发布未明显扭转市场对短期基本面的谨慎情绪。公开信息显示,市场一致预期公司本季度营收约1.48亿美元,同比增长3.77%;调整后每股收益预计为-0.26美元,息税前利润预计为-3669.57万美元。当前资金更关注营收增速、毛利率及费用率的边际变化。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"10x Genomics夜盘下跌,AI新品难振市场信心","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173169340","title":"异动解读|10x Genomics, Inc.盘中上涨5.42%,AI单细胞分析工具发布带动关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1173169340","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173169340?lang=zh_cn&edition=full","pubTime":"2026-11-03 22:40","pubTimestamp":1793716849,"startTime":"0","endTime":"0","summary":"11月3日,10x Genomics, Inc.盘中上涨5.42%,报64.4美元/股,成交额695.49万美元。消息面上,公司此前宣布推出云端AI应用Sentira Single Cell,支持研究人员以自然语言分析Chromium单细胞数据,提升单细胞数据分析的便捷性与可用性。该工具面向公司Chromium单细胞数据使用场景,属于产品与软件能力拓展。在财报披露临近之际,这一新品发布为市场提供了新的关注点。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"10x Genomics股价拉升,AI单细胞工具引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194899109","title":"异动解读|10x Genomics, Inc.盘中下跌5.04%,AI单细胞分析工具发布未扭转谨慎情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1194899109","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194899109?lang=zh_cn&edition=full","pubTime":"2026-11-02 23:37","pubTimestamp":1793633823,"startTime":"0","endTime":"0","summary":"11月2日,10x Genomics, Inc.盘中下跌5.04%,报66.575美元/股,成交额5067.45万美元。消息面上,公司当天宣布推出云端AI应用Sentira Single Cell,支持研究人员以自然语言分析Chromium单细胞数据。不过,市场对公司短期基本面仍偏审慎。公司将于11月5日披露财报,当前一致预期季度营收约1.48亿美元,同比增长3.77%;调整后每股收益预计为-0.26美元,息税前利润预计为-3669.57万美元,资金更关注营收增速、毛利率及费用率变化。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"10x Genomics盘中下挫,AI新工具难振信心","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158858495","title":"异动解读|10x Genomics, Inc.盘中下跌9.15%,财报前机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1158858495","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158858495?lang=zh_cn&edition=full","pubTime":"2026-10-30 21:49","pubTimestamp":1793368178,"startTime":"0","endTime":"0","summary":"10月30日,10x Genomics, Inc.盘中下跌9.15%,报73.214美元/股,成交额4847.1万美元。消息面上,公司将于11月5日发布财报,当前市场一致预期本季度营收约1.48亿美元,同比增长3.77%;调整后每股收益预计为-0.26美元,息税前利润预计为-3669.57万美元,同比下降38.12%,机构整体观点偏审慎。从关注点看,市场主要聚焦本季度营收增速、毛利率兑现以及费用率边际变化;尽管公司上季度营收和每股亏损均好于预期,但在本次财报临近之际,资金情绪明显转向谨慎。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前机构观点偏审慎,10x Genomics盘中下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144995158","title":"异动解读|10x Genomics, Inc.盘前下跌5.58%,财报前机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1144995158","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144995158?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:14","pubTimestamp":1793358899,"startTime":"0","endTime":"0","summary":"10月30日,10x Genomics, Inc.盘前下跌5.58%,报77.2美元/股,成交额24.84万美元。消息面上,公司将于11月5日发布财报,市场一致预期本季度营收约1.48亿美元,同比增长3.77%;调整后每股收益预计为-0.26美元;息税前利润预计为-3669.57万美元,同比下降38.12%。当前市场对其营收增速、毛利率兑现及费用率边际变化保持审慎。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前机构观点审慎,10x Genomics盘前下挫","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196337377","title":"财报前瞻 | 10x Genomics, Inc.本季度营收预计小幅增长,机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1196337377","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196337377?lang=zh_cn&edition=full","pubTime":"2026-10-29 10:32","pubTimestamp":1793241139,"startTime":"0","endTime":"0","summary":"10x Genomics, Inc.将于2026年11月05日发布财报。市场一致预期显示,10x Genomics, Inc.本季度总收入预计为1.48亿美元,同比增长3.77%;调整后每股收益预计为-0.26美元,同比增长9.02%;息税前利润预计为-3,669.57万美元,同比下降38.12%。整体而言,观点偏谨慎,侧重关注本季度营收与毛利率兑现情况以及费用率的边际变化。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 10x Genomics, Inc.本季度营收预计小幅增长,机构观点偏审慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107719184","title":"异动解读|10x Genomics, Inc.盘中上涨5.42%,机构上调目标价后股价维持强势","url":"https://stock-news.laohu8.com/highlight/detail?id=1107719184","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107719184?lang=zh_cn&edition=full","pubTime":"2026-10-28 21:42","pubTimestamp":1793194978,"startTime":"0","endTime":"0","summary":"10月28日,10x Genomics, Inc.盘中上涨5.42%,报82.16美元/股,成交额1532.64万美元。本次异动的公开催化仍来自机构观点调整。较新的消息是,Stephens于10月23日将评级由增持下调至持平,但给出65美元目标价;更早前,BofA Securities于10月9日将目标价大幅上调至80美元,显著高于FactSet统计的58.80美元平均目标价,显示部分机构对公司估值中枢上修,推动股价维持强势。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"机构上调目标价,10x Genomics强势上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115940905","title":"异动解读|10x Genomics, Inc.盘中上涨5.16%,机构上调目标价后股价维持强势","url":"https://stock-news.laohu8.com/highlight/detail?id=1115940905","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115940905?lang=zh_cn&edition=full","pubTime":"2026-10-27 22:35","pubTimestamp":1793111713,"startTime":"0","endTime":"0","summary":"10月27日,10x Genomics, Inc.盘中上涨5.16%,报76.725美元/股,成交额1726.72万美元。近期消息面上,机构观点仍是主要催化。10月23日,Stephens将该股评级由增持下调至持平,但给出65美元目标价;更早前10月9日,BofA Securities将目标价大幅上调至80美元,高于市场58.80美元的平均目标价,显示部分机构对公司估值中枢明显抬升。10x Genomics, Inc.于2012年7月2日在特拉华州注册成立。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"机构上调目标价,10x Genomics盘中走强","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105965704","title":"异动解读|10x Genomics盘中下跌5.22%,报72.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105965704","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105965704?lang=zh_cn&edition=full","pubTime":"2026-10-22 22:01","pubTimestamp":1792677712,"startTime":"0","endTime":"0","summary":"10月22日,10x Genomics盘中下跌5.22%,报72.14美元/股,成交额3907.72万美元。10x Genomics所在的生命科学工具和服务行业中,快而精医药上涨0.42%,丹纳赫下跌0.02%,赛默飞世尔下跌1.11%,Medpace Holdings Inc.下跌0.64%,查尔斯河上涨0.95%。公司是一家生命科学技术公司,专注于开发创新产品和解决方案,以更高分辨率和更大规模分析复杂生物系统。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100294897","title":"异动解读|10x Genomics盘中上涨5.4%,暂无明确新催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1100294897","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100294897?lang=zh_cn&edition=full","pubTime":"2026-10-21 21:48","pubTimestamp":1792590536,"startTime":"0","endTime":"0","summary":"10月21日,10x Genomics盘中上涨5.4%,报75.32美元/股,成交额2137.04万美元。10x Genomics所在的生命科学工具和服务行业中,丹纳赫上涨3.09%,赛默飞世尔上涨1.86%,快而精医药上涨0.07%,Illumina上涨3.33%,查尔斯河上涨4.71%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181970767","title":"异动解读|10x Genomics盘中下跌5.24%,股价延续回调且缺乏新增明确催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1181970767","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181970767?lang=zh_cn&edition=full","pubTime":"2026-10-16 21:51","pubTimestamp":1792158661,"startTime":"0","endTime":"0","summary":"10月16日,10x Genomics盘中下跌5.24%,报68.6美元/股,成交额1495.51万美元。近期公司虽先后获得美国银行证券将目标价上调至80美元、与Fred Hutchinson Cancer Center展开研究合作,并启动Atera平台商业发货,但最新可见信息未显示与本次下跌直接对应的新增事件催化,股价仍延续此前回调走势。同属生命科学工具和服务行业,赛默飞世尔跌0.7%,丹纳赫跌1.02%,Tempus AI跌4.34%,Illumina跌1.63%,安捷伦科技跌0.19%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10x Genomics盘中下行,股价延续回调走势","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101910866","title":"异动解读|10x Genomics盘中下跌5.02%,股价延续回调且缺乏新增明确催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1101910866","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101910866?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:03","pubTimestamp":1792073021,"startTime":"0","endTime":"0","summary":"10月15日,10x Genomics盘中下跌5.02%,报70.2美元/股,成交额4609.91万美元。公司近期虽获美国银行证券将目标价上调至80美元,此前亦宣布与Fred Hutchinson Cancer Center展开研究合作,并启动Atera平台商业发货,但最新可见信息未显示与本次下跌直接对应的新增事件催化,股价短线仍延续此前回调走势。10x Genomics所在的生命科学工具和服务行业表现分化,赛默飞世尔上涨1.77%,丹纳赫上涨2.29%,Illumina下跌1.69%,Tempus AI下跌1.03%,REVVITY INC下跌0.39%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136046107","title":"异动解读|10x Genomics盘中下跌5.17%,行业整体走弱叠加市场情绪谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1136046107","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136046107?lang=zh_cn&edition=full","pubTime":"2026-10-12 22:56","pubTimestamp":1791817011,"startTime":"0","endTime":"0","summary":"10月12日,10x Genomics盘中下跌5.17%,报76.58美元/股,成交额5131.77万美元。10x Genomics所在的生命科学工具和服务行业中,个股普遍承压,赛默飞世尔下跌0.24%,丹纳赫上涨0.03%,沃特世下跌1.27%,Illumina下跌2.97%,Tempus AI下跌3.16%。10x Genomics, Inc.于2012年7月2日在特拉华州注册成立,是一家生命科学技术公司,专注于开发创新的产品和解决方案,以探究、理解并掌控生物学。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159599834","title":"异动解读|10x Genomics盘中上涨6.25%,美银上调目标价提振市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1159599834","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159599834?lang=zh_cn&edition=full","pubTime":"2026-10-09 21:39","pubTimestamp":1791553141,"startTime":"0","endTime":"0","summary":"10月9日,10x Genomics盘中上涨6.25%,报82.04美元/股,成交额2409.95万美元。美银证券将公司目标价从50美元大幅上调至80美元,成为股价上涨的主要催化因素。此前一日公司宣布与Fred Hutchinson癌症中心达成多项目研究合作,但消息未能提振股价,反而出现下跌。10x Genomics是一家生命科学技术公司,专注于开发创新的产品和解决方案,以探究、理解并掌控生物学。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美银大幅上调目标价,10x Genomics盘中走强","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195965129","title":"异动解读|10x Genomics盘中下跌5.26%,Fred Hutchinson合作未能提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1195965129","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195965129?lang=zh_cn&edition=full","pubTime":"2026-10-08 21:38","pubTimestamp":1791466732,"startTime":"0","endTime":"0","summary":"10月8日,10x Genomics盘中下跌5.26%,报72.22美元/股,成交额2616.98万美元。公司宣布与Fred Hutchinson癌症中心达成多项目研究合作,推进实体瘤和血液癌领域的单细胞及空间技术,但该消息未能提振股价。第一个项目将使用Flex Apex和Xenium平台识别晚期膀胱癌患者的治疗反应生物标志物,第二个项目则利用Flex Apex评估急性髓系白血病治疗后残留病灶检测的改善潜力。10x Genomics是一家生命科学技术公司,专注于开发创新的产品和解决方案,以探究、理解并掌控生物学。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129676824","title":"异动解读|10x Genomics盘前下跌5.15%,与Fred Hutchinson合作未能提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1129676824","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129676824?lang=zh_cn&edition=full","pubTime":"2026-10-08 20:02","pubTimestamp":1791460971,"startTime":"0","endTime":"0","summary":"10月8日,10x Genomics盘前下跌5.15%,报72.10美元/股,成交额96.99万美元。消息面上,公司宣布与Fred Hutchinson癌症中心达成多项目研究合作,推进实体瘤和血液癌领域的单细胞及空间技术,但该消息未能提振股价。第一个项目将使用Flex Apex和Xenium平台识别晚期膀胱癌患者的治疗反应生物标志物,第二个项目则利用Flex Apex评估急性髓系白血病治疗后残留病灶检测的改善潜力。10x Genomics, Inc.是一家生命科学技术公司,专注于开发创新的产品和解决方案,以探究、理解并掌控生物学。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10x Genomics盘前下跌,与Fred Hutch合作难振信心","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119192351","title":"异动解读|10x Genomics盘中下跌6.72%,生命科学工具板块集体走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1119192351","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119192351?lang=zh_cn&edition=full","pubTime":"2026-10-07 21:36","pubTimestamp":1791380209,"startTime":"0","endTime":"0","summary":"10月7日,10x Genomics盘中下跌6.72%,报73.83美元/股,成交额5531.5万美元。公司所在的生命科学工具和服务行业中,赛默飞世尔跌0.02%,Tempus AI跌3.13%,Illumina跌2.37%,丹纳赫跌0.28%,Azenta跌7.8%,板块整体表现低迷,技术平台类个股普遍承压。10x Genomics专注于开发单细胞及空间分析技术,通过整合仪器、耗材和软件提供生物系统研究解决方案。近期公司首批Atera空间生物学平台商业发货落地,并获Argus Research买入评级及110美元目标价,但板块系统性回调压力主导了当日股价走势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10x Genomics走弱,生命科学板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181148470","title":"异动解读|10x Genomics盘中下跌6.13%,行业板块集体回调施压","url":"https://stock-news.laohu8.com/highlight/detail?id=1181148470","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181148470?lang=zh_cn&edition=full","pubTime":"2026-10-06 22:09","pubTimestamp":1791295743,"startTime":"0","endTime":"0","summary":"10月6日,10x Genomics盘中下跌6.13%,报91.56美元/股,成交额1.11亿美元。公司所在的生命科学工具和服务行业中,个股普遍走弱,其中Illumina跌0.65%,赛默飞世尔跌0.07%,Tempus AI跌4.91%,查尔斯河涨2.01%,丹纳赫涨0.21%,板块整体表现低迷,技术平台类个股承受抛压。10x Genomics专注于开发单细胞及空间分析技术,通过整合仪器、耗材和软件提供生物系统研究解决方案。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113997926","title":"异动解读|10x Genomics盘中上涨5.06%,首批Atera平台商业发货落地叠加投行看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1113997926","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113997926?lang=zh_cn&edition=full","pubTime":"2026-10-06 03:46","pubTimestamp":1791229613,"startTime":"0","endTime":"0","summary":"10月6日,10x Genomics盘中上涨5.06%,报98.25美元/股,成交额1.87亿美元。消息面上,公司上周宣布空间生物学平台Atera启动首批商业发货,该平台整合全转录组分析与单细胞分辨率能力,并计划用于AI生物学模型训练。同时Argus Research上周给予买入评级及110美元目标价,较FactSet平均目标溢价87%。公司所在的生命科学工具服务行业中,Illumina当日上涨8.21%,Tempus AI上涨8.86%,显示技术平台类个股受资金青睐。该公司专注于开发单细胞及空间分析技术,通过整合仪器、耗材和软件提供生物系统研究解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128158620","title":"异动解读|10x Genomics盘中上涨5.55%,新平台Atera启动商业发货叠加投行看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1128158620","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128158620?lang=zh_cn&edition=full","pubTime":"2026-10-02 22:25","pubTimestamp":1790951113,"startTime":"0","endTime":"0","summary":"10月2日,10x Genomics盘中上涨5.55%,报93.69美元/股,成交额6291.16万美元。消息面上,公司近日宣布其全新空间生物学平台Atera正式启动首批商业发货。与此同时,Argus Research此前首次覆盖10x Genomics并给予买入评级,目标价110美元,显著高于FactSet汇总的分析师一致目标价58.80美元。此外,UBS此前亦大幅上调目标价至68美元。新产品商业化里程碑叠加多家投行看多,持续推动股价走强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Atera启动商业发货,10x Genomics盘中上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.10xgenomics.com","stockEarnings":[{"period":"1week","weight":-0.1925},{"period":"1month","weight":-0.3092},{"period":"3month","weight":0.4807},{"period":"6month","weight":2.1259},{"period":"1year","weight":4.0539},{"period":"ytd","weight":3.1398}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0104},{"period":"3month","weight":-0.0023},{"period":"6month","weight":0.0396},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.1245}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"10x Genomics, Inc.于2012年7月2日在特拉华州注册成立。该公司是一家生命科学技术公司,专注于开发创新的产品和解决方案,以探究、理解并掌控生物学。该公司的集成研究解决方案包括用于分析生物系统的仪器、耗材和软件,其分析的分辨率和规模能够与生物学的复杂性相匹配。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.052337},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.036275},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.07872},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.041692},{"month":5,"riseRate":0.571429,"avgChangeRate":0.022907},{"month":6,"riseRate":0.714286,"avgChangeRate":0.088413},{"month":7,"riseRate":0.714286,"avgChangeRate":0.072776},{"month":8,"riseRate":0.571429,"avgChangeRate":0.037524},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.025356},{"month":10,"riseRate":0.5,"avgChangeRate":-0.022646},{"month":11,"riseRate":0.625,"avgChangeRate":0.146831},{"month":12,"riseRate":0.285714,"avgChangeRate":0.010479}],"exchange":"NASDAQ","name":"10x Genomics, Inc.","nameEN":"10x Genomics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"10x Genomics, Inc.(TXG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供10x Genomics, Inc.(TXG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"10x Genomics, Inc.,TXG,10x Genomics, Inc.股票,10x Genomics, Inc.股票老虎,10x Genomics, Inc.股票老虎国际,10x Genomics, Inc.行情,10x Genomics, Inc.股票行情,10x Genomics, Inc.股价,10x Genomics, Inc.股市,10x Genomics, Inc.股票价格,10x Genomics, Inc.股票交易,10x Genomics, Inc.股票购买,10x Genomics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"10x Genomics, Inc.(TXG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供10x Genomics, Inc.(TXG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}